Filing Details

Accession Number:
0001209191-16-146633
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-10-21 18:06:57
Reporting Period:
2016-10-19
Filing Date:
2016-10-21
Accepted Time:
2016-10-21 18:06:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1044378 Biocept Inc BIOC Services-Medical Laboratories (8071) 330757995
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1598736 Claire Reiss C/O Biocept, Inc.
5810 Nancy Ridge Drive #150
San Diego CA 92121
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-10-19 227,272 $1.10 1,046,613 No 4 P Indirect By trusts
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By trusts
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2016-10-19 227,272 $0.00 227,272 $1.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
227,272 2016-10-19 2021-10-19 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,672 Indirect By corporation
Footnotes
  1. Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit.
  2. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 1,638,675 fewer shares.
  3. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 9,340 fewer shares.